Joseph K. Belanoff
Known title: Chief Executive OfficerCIK: 0001286199
Associated companies
Transaction History
| CORT | ▼ Sell | Open Market | 12,837 | $895K | 6/1/2026 | View on chart |
| CORT | ▼ Sell | Gift | 300,000 | $0 | 5/29/2026 | View on chart |
| CORT | ▼ Sell | Gift | 150,000 | $0 | 5/29/2026 | View on chart |
| CORT | ▼ Sell | Gift | 150,000 | $0 | 5/29/2026 | View on chart |
| CORT | ▼ Sell | Open Market | 40,000 | $2.0M | 5/1/2026 | View on chart |
| CORT | ▼ Sell | Open Market | 26,198 | $1.3M | 3/25/2026 | View on chart |
| CORT | ▼ Sell | Tax Withholding | 306,846 | $25.6M | 12/24/2025 | View on chart |
| CORT | ▼ Sell | Other | 243,154 | $0 | 12/24/2025 | View on chart |
| CORT | ▲ Buy | Option Exercise | 550,000 | $2.1M | 12/24/2025 | View on chart |
| CORT | ▼ Sell | Gift | 243,154 | $0 | 12/24/2025 | View on chart |
| CORT | ▼ Sell | Open Market | 40,000 | $3.2M | 12/1/2025 | View on chart |
| CORT | ▼ Sell | Open Market | 3,590 | $273K | 11/5/2025 | View on chart |
| CORT | ▼ Sell | Open Market | 14,355 | $1.1M | 11/5/2025 | View on chart |
| CORT | ▼ Sell | Open Market | 10,837 | $814K | 11/5/2025 | View on chart |
| CORT | ▼ Sell | Open Market | 11,218 | $831K | 11/3/2025 | View on chart |
| CORT | ▼ Sell | Open Market | 31,190 | $2.7M | 10/1/2025 | View on chart |
| CORT | ▼ Sell | Open Market | 3,194 | $274K | 10/1/2025 | View on chart |
| CORT | ▼ Sell | Open Market | 5,616 | $473K | 10/1/2025 | View on chart |
| CORT | ▼ Sell | Open Market | 39,300 | $2.8M | 9/2/2025 | View on chart |
| CORT | ▼ Sell | Open Market | 700 | $50K | 9/2/2025 | View on chart |
| CORT | ▼ Sell | Open Market | 16,745 | $1.1M | 8/1/2025 | View on chart |
| CORT | ▼ Sell | Open Market | 17,809 | $1.2M | 8/1/2025 | View on chart |
| CORT | ▼ Sell | Open Market | 5,446 | $379K | 8/1/2025 | View on chart |
| CORT | ▼ Sell | Open Market | 615 | $45K | 7/17/2025 | View on chart |
| CORT | ▼ Sell | Open Market | 1,263 | $104K | 6/2/2025 | View on chart |
| CORT | ▼ Sell | Open Market | 1,820 | $148K | 6/2/2025 | View on chart |
| CORT | ▼ Sell | Open Market | 2,988 | $240K | 6/2/2025 | View on chart |
| CORT | ▼ Sell | Open Market | 4,881 | $383K | 6/2/2025 | View on chart |
| CORT | ▼ Sell | Open Market | 3,050 | $242K | 6/2/2025 | View on chart |
| CORT | ▼ Sell | Open Market | 8,408 | $715K | 6/2/2025 | View on chart |
| CORT | ▼ Sell | Open Market | 12,959 | $1.1M | 6/2/2025 | View on chart |
| CORT | ▼ Sell | Open Market | 4,631 | $387K | 6/2/2025 | View on chart |
| CORT | ▼ Sell | Open Market | 18,480 | $1.3M | 5/2/2025 | View on chart |
| CORT | ▼ Sell | Open Market | 21,520 | $1.6M | 5/2/2025 | View on chart |
| CORT | ▼ Sell | Open Market | 350 | $40K | 4/1/2025 | View on chart |
| CORT | ▼ Sell | Open Market | 35,102 | $3.3M | 3/31/2025 | View on chart |
| CORT | ▼ Sell | Open Market | 1,974 | $120K | 3/24/2025 | View on chart |
| CORT | ▼ Sell | Open Market | 2,924 | $178K | 3/3/2025 | View on chart |
| CORT | ▲ Buy | Option Exercise | 450,000 | $1.5M | 7/31/2024 | View on chart |
| CORT | ▼ Sell | Tax Withholding | 259,583 | $10.0M | 7/31/2024 | View on chart |
| CORT | ▼ Sell | Open Market | 55,111 | $1.4M | 7/7/2022 | View on chart |
| CORT | ▲ Buy | Option Exercise | 800,000 | $1.7M | 7/6/2022 | View on chart |
| CORT | ▼ Sell | Tax Withholding | 451,189 | $11.8M | 7/6/2022 | View on chart |
| CORT | ▼ Sell | Open Market | 279,908 | $7.4M | 7/6/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 4, 2026
CORT Featured in Low-Beta Healthcare Stock List
Corcept Therapeutics was included in a recent list of low-beta healthcare stocks, highlighting its potential stability amid market concerns about interest rates. The company currently trades within its 52-week range, with a high trailing P/E ratio of 227.7. Analysts maintain an average price target of $141.00, reflecting a wide range of expectations for the stock's future performance.
CORT Featured in Low-Beta Healthcare Stock List. Corcept Therapeutics was included in a recent list of low-beta healthcare stocks, highlighting its potential stability amid market concerns about interest rates. The company currently trades within its 52-week range, with a high trailing P/E ratio of 227.7. Analysts maintain an average price target of $141.00, reflecting a wide range of expectations for the stock's future performance.